Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Manipulation of neuronal ion channels

a technology of ion channels and neuronal cells, applied in the field of manipulation of neuronal ion channels, can solve the problems of reducing the availability of dopamine, preventing the typical progressive changes of the brain, and drug side effects in some people, so as to inhibit the ability of a fast-spiking neuronal cell to discharge at high rates, inhibit the ability of the neuronal cell to discharge, and reduce the expression of kv3.4 protein

Inactive Publication Date: 2010-04-15
NORTHWESTERN UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides methods for inhibiting the high frequency neuronal bursts associated with Parkinson's disease and other neurological diseases and conditions. This is achieved by decreasing the ability of fast-spiking neurons to discharge at high rates. The methods involve inhibiting the Kv3.4 subunit of Kv3 channels, which can be achieved by using toxins, small molecule drugs, antibodies, or other methods. The invention also provides methods for screening compounds that specifically interfere with Kv3 channel function, and for treating neurological conditions or disorders associated with Kv3 channels.

Problems solved by technology

Parkinson's disease is caused by the degeneration of the pigmented neurons in the Substantia Nigra of the brain, resulting in decreased dopamine availability.
Treatment with levodopa does not, however, prevent the progressive changes of the brain typical of Parkinson's disease.
The drug may also produce side effects in some people, due to its change to dopamine before reaching the brain.
Thus, patients experienced debilitating side effects, including severe nausea and vomiting.
Most effective in the control of tremor, these drugs may be contraindicated in certain older patients since they tend to cause confusion and hallucination.
Unfortunately, all of the medications currently available exhibit undesirable side effects.
As with any surgical procedure, there are risks involved.
The most serious is the possibility of stroke; other risks include partial loss of vision, speech and swallowing difficulties, and confusion, as well as the general risks associated with surgery.
All of the treatments described above suffer from drawbacks, some serious, which debilitate the patient and compromise the quality of life.
Moreover, none of these treatments provide a cure for the disease.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

Methods

[0220]This example describes the methods used in discovering the role of the subunit Kv3.4 in FS neurons.

[0221]Tissue preparation. Neurons from the GP, subthalamic nucleus, inferior colliculus and CA1 area of hippocampus from young adult rats were acutely dissociated, using procedures similar to those we have described previously27. Hippocampal interneurons and GP were identified as CaMKII negative, GAD67 and parvalbumin positive neurons by single cell RT-PCR detection of corresponding mRNAs following physiology experiments (see below).

[0222]Electrophysiology. Whole-cell recordings used standard techniques27,28. The internal solution consisted of (in mM): 30-90 K2SO4, 0-60 N-methyl-D-glucamine, 2 MgCl2, 40 HEPES, 5 EGTA, 12 phosphocreatine, 2 Na2ATP, 0.2 Na3GTP, and 0.1 leupeptin, pH 7.2 with H2SO4 (osmolarity 260-270 mOsm / 1). The external solution consisted of (in mM): 140 Na-isethionate, 2 KCl, 4 MgCl2, 10 HEPES, 12 glucose and 0.001 TTX, pH 7.35 with NaOH (osmolarity 295-3...

example 2

Kv3.1 Homomeric Channels Differ from FS Delayed Rectifier Channels

[0227]Three types of neuron (identified by scRT-PCR) in which Kv3 channel currents are thought to be key regulators of repetitive activity were studied: parvalbumin-expressing GABAergic, globus pallidus neurons, parvalbumin-expressing, GABAergic CA1 hippocampal interneurons and glutamatergic subthalamic neurons10,11,14. All three types of neuron are capable of sustained high frequency (>100 Hz) discharge without significant accommodation and will be referred to as fast-spiking (FS). A key feature of Kv3 channel currents in these neurons is their activation during the up-stroke of the spike, leading to rapid repolarization of the membrane potential and brief spikes. The ability to be activated efficiently during the upstroke of the spike depends upon the voltage at which channels begins to open and the rate at which they enter the open state.

[0228]In FS neurons, tetraethylammonium (TEA)-sensitive, Kv3 channels begin to...

example 3

FS Neurons Co-Express Kv3.1 and Kv3.4a Subunits

[0231]In agreement with in situ hybridization work previously reported8, prior scRT-PCR studies by the inventors had shown that GABAergic GP neurons expressed Kv3.1 mRNA and TEA-sensitive, fast delayed rectifier channels11. As a first step toward understanding the origin of the biophysical difference between these FS neuronal channels in situ and Kv3.1 homomeric channels expressed in HEK293 cells, scRT-PCR profiling of the FS neurons was expanded to include the other members of the Kv3 family, despite previous reports that Kv3.3 and Kv3.4. Kv3.3 mRNA was rarely detected in GP neurons.

[0232]But in contrast to previous reports, GABAergic GP neurons consistently expressed both Kv3.1 and Kv3.4 mRNAs. Kv3.4 mRNA was detected in 96% (45 / 47) of the GP sample. In fact, GP neurons co-expressed two of the three known Kv3.4 splice variants. These splice variants appeared as a small (c variant, 460 bp) and a large (a variant, 522 bp) amplicon in th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
frequencyaaaaaaaaaa
frequencyaaaaaaaaaa
voltagesaaaaaaaaaa
Login to View More

Abstract

The present invention provides compositions and methods for the manipulation of ion channels. For example, the present invention relates to Parkinson's and other neurological diseases and conditions, and treatments thereof. In particular, the present invention provides methods of decreasing pathophysiological high frequency neuronal bursts of Parkinson's and other neurological diseases and conditions. Methods of the present invention comprise decreasing Kv3 ion channel activity in fast-spiking neurons, including by decreasing activity of a Kv3.4 protein and by specifically targeting a Kv3.4 protein with an inhibitor.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of U.S. patent application Ser. No. 10 / 761,557, (allowed), filed: Jan. 21, 2004, which claims priority to U.S. Provisional Patent Application Ser. No. 60 / 441,375, filed: Jan. 21, 2003, both of which are herein incorporated by reference in their entirety.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT[0002]The present application was made with government support under grant number PO1 ns-26473 from the National Institutes of Health National Institute of Neurological and Stroke Disease. The government has certain rights in the invention.FIELD OF THE INVENTION[0003]The present invention provides compositions and methods for the manipulation of ion channels. For example, the present invention relates to Parkinson's and other neurological diseases and conditions, and treatments thereof. In particular, the present invention provides methods of decreasing pathophysiological high frequency neuron...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K48/00A61K38/16C12Q1/68G01N33/53A61K35/12C12N5/0793C12N5/0797G01N33/68
CPCA61K35/12A61K38/16C12N5/0619G01N33/6896C12N2510/00G01N33/6872C12N5/0623
Inventor SURMEIER, D. JAMESTKATCH, TATIANABARANAUSKAS, GYTIS
Owner NORTHWESTERN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products